Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M

image via TechCrunch

May 3, 2024, 5:20 PM

Allozymes uses a microfluidics system to rapidly test millions of enzymes, which could be used in a variety of industries. The company has raised a $15 million Series A to grow its business and develop new AI-based tools.

Read original article